Back to School: How biopharma can reboot drug development. Access exclusive analysis here

TB-402: Phase II start

Next half, the partners will begin a dose-ranging,

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE